Abbott India Ltd. logo

Abbott India Ltd. (ABBOTINDIA)

Market Open
12 Jun, 10:00
XNSE XNSE
26,280. 00
+215
+0.8249%
584.44B Market Cap
- P/E Ratio
1,640% Div Yield
9,732 Volume
- Eps
26,065
Previous Close
Add Transaction
Day Range
25,960 26,435
Year Range
25,150 37,000
Want to track ABBOTINDIA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ABBOTINDIA trading today higher at ₹26,280, an increase of 0.8249% from yesterday's close, completing a monthly increase of 3.3222% or ₹845. Over the past 12 months, ABBOTINDIA stock lost -8.9397%.
ABBOTINDIA pays dividends to its shareholders, with the most recent payment made on Sep 12, 2025. The next announced payment will be in In 2 months on Aug 18, 2026 for a total of ₹656.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Abbott India Ltd. has completed 1 stock splits, with the recent split occurring on Aug 17, 1998.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

ABBOTINDIA Chart

People also search for

Apollo Hospitals Enterprise Ltd.
8,498
+0.0589%
Fortis Healthcare Ltd.
990.35
+0.1365%
GlaxoSmithKline Pharmaceuticals Ltd.
2,121
+0.8463%
Biocon Ltd.
419
+0.7333%
Krishna Institute of Medical Sciences Ltd.
785.1
+2.5738%

Abbott India Ltd. (ABBOTINDIA) FAQ

What is the stock price today?

The current price is ₹26,280.00.

On which exchange is it traded?

Abbott India Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is ABBOTINDIA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1,640%.

What is its market cap?

As of today, the market cap is 584.44B.

Has Abbott India Ltd. ever had a stock split?

Abbott India Ltd. had 1 splits and the recent split was on Aug 17, 1998.

Abbott India Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
XNSE Exchange
Y4810G125 CUSIP
India Country
3,814 Employees
24 Jul 2026 Last Dividend
17 Aug 1998 Last Split
- IPO Date

Overview

Abbott India Limited, a prominent subsidiary of Abbott Capital India Limited, establishes its presence firmly within the Indian pharmaceutical industry. With its foundations laid in 1910 and headquartered in Mumbai, India, the company has matured into a significant player, leveraging its extensive experience and expertise in healthcare. It engages in the development, manufacture, and marketing of a comprehensive range of pharmaceutical products. Its operations are diversified across various therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system issues, and includes a strong emphasis on vaccines and multispecialty solutions. Abbott India Limited's commitment to addressing diverse medical needs has positioned it as a key contributor to the healthcare sector in India.

Products and Services

  • Gastroenterology:

    Specialized products aimed at improving digestive health and treating conditions related to the gastrointestinal tract.

  • Women's Health:

    Comprehensive healthcare solutions targeting various stages of a woman's life, focusing on reproductive health and other specific needs.

  • Metabolic:

    Medications designed to manage metabolic disorders, providing options for patients with diabetes, obesity, and related conditions.

  • Central Nervous System:

    Therapies for treating diseases and conditions affecting the brain and nerves, including mental health and neurological disorders.

  • Vaccines:

    A range of immunizations to prevent various infectious diseases, reinforcing public health efforts.

  • Multispecialty:

    Diverse treatments for conditions spanning from insomnia and vitamin D deficiency to pre-term labor and pain management.

  • Anti-infective:

    Products developed to combat infections, ensuring effective treatment for bacterial, viral, and other types of infectious diseases.

  • Cardio-diabeto:

    Treatments focused on cardiovascular diseases and diabetes, offering a multi-disciplinary approach to managing these chronic conditions.

  • Hepatology:

    Medications specifically targeted at treating liver diseases, supporting overall liver health and function.

  • Hormones:

    Therapeutic solutions focusing on hormone-related disorders, balancing endocrine health.

  • Neuro-psychiat:

    Advanced treatments for psychiatric and neurologic conditions, aiming to improve mental health and cognitive functions.

  • Hepatic:

    Specialized focus on managing hepatic conditions, including treatments for liver diseases beyond the scope of hepatology.

  • Gennext:

    Next-generation healthcare solutions incorporating the latest advancements in medicine and technology.

  • Consumer Care:

    Over-the-counter products that cater to everyday health and wellness needs, making healthcare accessible to the wider public.

Contact Information

Address: Godrej BKC, Plot C-68
Phone: 91 22 5046 1000